Steven D. Kahl

5.6k citations

51 papers · 4.3k indexed · 2 hit papers · h-index 23

Molecular Biology top 2%
Cellular and Molecular Neuroscience top 1%
Physiology top 2%
Cardiology and Cardiovascular Medicine top 2%
Cell Biology top 2%

Co-authors: Kevin P. Campbell James M. Ervasti Kay Ohlendieck Kiichiro Matsumura Larry C. Blaszczak Timothy I. Meier Genshi Zhao Kyle R. Gee
Topics: Adipose Tissue and Metabolism (10 papers)Muscle Physiology and Disorders (9 papers)Ion channel regulation and function (8 papers)
Cited by: Rehabilitation Cellular and Molecular Neuroscience Molecular Biology
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United States Spain Switzerland

In The Last Decade

Steven D. Kahl

50 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle

1990 846 citations James M. Ervasti, Kay Ohlendieck et al. Nature profile →
Association of dystrophin and an integral membrane glycoprotein

1989 618 citations Kevin P. Campbell, Steven D. Kahl Nature profile →

Peers

Countries citing papers authored by Steven D. Kahl

Since Specialization

Citations

This map shows the geographic impact of Steven D. Kahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven D. Kahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven D. Kahl more than expected).

Fields of papers citing papers by Steven D. Kahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven D. Kahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven D. Kahl. The network helps show where Steven D. Kahl may publish in the future.

Co-authorship network of co-authors of Steven D. Kahl

This figure shows the co-authorship network connecting the top 25 collaborators of Steven D. Kahl. A scholar is included among the top collaborators of Steven D. Kahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven D. Kahl. Steven D. Kahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical Characterization of Once Weekly Basal Insulin Fc (BIF) 2021 ·Journal of the Endocrine Society ·Julie S. Moyers,Ryan J. Hansen,Jonathan W. Day,Craig D. Dickinson,Chen Zhang,Steven D. Kahl,Xiaoping Ruan,Liyun Ding,Robin M. Brown,Hana E. Baker,John M. Beals	6
2	Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP) 2020 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Joseph D. Ho,Matthew R. Lee,Charles T. Rauch,(unknown),(unknown),J.G. Luz,Stephen Antonysamy,Bradley Condon,(unknown),Aiping Zhang,(unknown),(unknown),Srinivasan Chandrasekhar,(unknown),Karen M. Gooding,Anita K. Harvey,Xiaopeng Yu,Steven D. Kahl,Bryan H. Norman	17
3	Insulin exits skeletal muscle capillaries by fluid-phase transport 2018 ·Journal of Clinical Investigation ·Ian M. Williams,(unknown),Steven D. Kahl,Doraiswami Ramkrishna,Adam R. Mezo,Jamey D. Young,K. Sam Wells,David H. Wasserman	36
4	In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin Analog 2016 ·Journal of Pharmacology and Experimental Therapeutics ·Robyn Owens,R. J. Hansen,Steven D. Kahl,Chunhua Zhang,Xiaoping Ruan,(unknown),Shun Li,(unknown),Mark W. Farmen,(unknown),Julie S. Moyers,Gordon B. Cutler,A. Vick,John M. Beals	15
5	A selective GPR40 (FFAR1) agonist LY2881835 provides immediate and durable glucose control in rodent models of type 2 diabetes 2016 ·Pharmacology Research & Perspectives ·Yanyun Chen,Min Song,Jonathan Riley,(unknown),(unknown),Donalyn Scheuner,Krister Bokvist,Pranab Maiti,Steven D. Kahl,Chahrzad Montrose‐Rafizadeh,Chafiq Hamdouchi,Anne Reifel Miller	19
6	Discovery of a Novel Series of Orally Active Nociceptin/Orphanin FQ (NOP) Receptor Antagonists Based on a Dihydrospiro(piperidine-4,7′-thieno[2,3-c]pyran) Scaffold 2014 ·Journal of Medicinal Chemistry ·Miguel A. Toledo,Concepción Pedregal,(unknown),Nuria Cirauqui,A. MARTINEZ‐GRAU,Alma Jiménez,(unknown),Alicia Torrado,Carlos Mateos,Elizabeth Joshi,Steven D. Kahl,Karen Rash,Daniel R. Mudra,Vanessa Barth,David B. Shaw,David L. McKinzie,Jeffrey M. Witkin,Michael A. Statnick	49
7	Basics of Enzymatic Assays for HTS 2012 ·Harold B. Brooks,Sandaruwan Geeganage,Steven D. Kahl,Chahrzad Montrose,(unknown),(unknown),Jeffrey R. Weidner	24
8	Assay Operations for SAR Support 2012 ·Europe PMC (PubMed Central) ·Benoît Beck,Yunfei Chen,(unknown),Viswanath Devanarayan,Brian J. Eastwood,Mark W. Farmen,Stephen J. Iturria,(unknown),Steven D. Kahl,Roger A. Moore,Barry D. Sawyer,Jeffrey R. Weidner	14
9	Structure-Activity Relationships of β -MSH Derived Melanocortin-4 Receptor Peptide Agonists 2007 ·Current Topics in Medicinal Chemistry ·Liang Yan,Hansen M. Hsiung,Mark L. Heiman,Robert A. Gadski,(unknown),(unknown),David B. Flora,Patrick J. B. Edwards,D. L. Smiley,Lianshan Zhang,(unknown),Steven D. Kahl,(unknown),John P. Mayer	10
10	Potent and selective MC-4 receptor agonists based on a novel disulfide scaffold 2005 ·Bioorganic & Medicinal Chemistry Letters ·Liang Yan,David B. Flora,Patrick J. B. Edwards,David L. Smiley,Paul J. Emmerson,Hansen M. Hsiung,Robert A. Gadski,(unknown),Mark L. Heiman,(unknown),Thomas P. O’Brien,Steven D. Kahl,Lianshan Zhang,Richard D. DiMarchi,John P. Mayer	8
11	High-throughput screening: advances in assay technologies 1997 ·Current Opinion in Chemical Biology ·G. Sitta Sittampalam,Steven D. Kahl,William P. Janzen	110
12	A Multiple-Approach Scintillation Proximity Assay to Measure the Association between Ras and Raf 1996 ·Analytical Biochemistry ·Steven D. Kahl,(unknown),(unknown),Joseph Manetta	4
13	Absence of the Skeletal Muscle Sarcolemma Chloride Channel ClC-1 in Myotonic Mice 1995 ·Journal of Biological Chemistry ·Christina A. Gurnett,Steven D. Kahl,Richard D. Anderson,Kevin P. Campbell	61
14	[28] Purification and reconstitution of N-type calcium channel complex from rabbit brain 1994 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Derrick R. Witcher,Michel De Waard,Steven D. Kahl,Kevin P. Campbell	11
15	Radioimmunoassay for the Calcium Release Channel Agonist Ryanodine 1994 ·Analytical Biochemistry ·Steven D. Kahl,Peter S. McPherson,T. Lewis,P. Bentley,(unknown),John D. Windass,Kevin P. Campbell	5
16	Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle 1992 ·Nature ·Kiichiro Matsumura,James M. Ervasti,Kay Ohlendieck,Steven D. Kahl,Kevin P. Campbell	440
17	Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle 1991 ·Neuron ·Kay Ohlendieck,James M. Ervasti,Kiichiro Matsumura,Steven D. Kahl,(unknown),Kevin P. Campbell	330
18	Deficiency of a glycoprotein component of the dystrophin complex in dystrophic musclebreakdown → 1990 ·Nature ·James M. Ervasti,Kay Ohlendieck,Steven D. Kahl,(unknown),Kevin P. Campbell	846
19	Association of dystrophin and an integral membrane glycoproteinbreakdown → 1989 ·Nature ·Kevin P. Campbell,Steven D. Kahl	618
20	A monoclonal antibody to the Ca²⁺ ‐ATPase of cardiac sarcoplasmic reticulum cross‐reacts with slow type I but not with fast type II canine skeletal muscle fibers: An immunocytochemical and immunochemical study 1988 ·Cell Motility and the Cytoskeleton ·A O Jorgensen,(unknown),D. R. Pepper,Steven D. Kahl,(unknown),Kevin P. Campbell	89

About Steven D. Kahl

Steven D. Kahl is a scholar working on Behavioral Neuroscience, Cellular and Molecular Neuroscience and Molecular Biology, having authored 51 papers that have together received 4.3k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (10 papers), Muscle Physiology and Disorders (9 papers) and Ion channel regulation and function (8 papers). The work is most often cited by research in Rehabilitation (522 citations), Cellular and Molecular Neuroscience (1.2k citations) and Molecular Biology (3.6k citations). Steven D. Kahl has collaborated with scholars based in United States, Spain and Switzerland. Frequent co-authors include Kevin P. Campbell, James M. Ervasti, Kay Ohlendieck, Kiichiro Matsumura, Larry C. Blaszczak, Timothy I. Meier, Genshi Zhao, Kyle R. Gee, G. Sitta Sittampalam and William P. Janzen. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact